Schalkwijk, S., Heine, R. T., Colbers, A. C., Huitema, A. D., Denti, P., Dooley, K. E., . . . Burger, D. M. (2018). A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.
Chicago Style CitationSchalkwijk, Stein, et al. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 Mg in Pregnant Women. 2018.
MLA引文Schalkwijk, Stein, et al. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 Mg in Pregnant Women. 2018.
警告:這些引文格式不一定是100%准確.